Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Elevidys, Sarepta Therapeutics and gene

The Boston Globe · 8h
Sarepta soars after FDA says some patients can get Elevidys
Sarepta Therapeutics Inc. shares rose sharply early Tuesday after US regulators reversed course and recommended that patients who can walk be allowed to take its gene therapy Elevidys again.
Reuters on MSN · 1d
Sarepta resumes shipping of gene therapy Elevidys to patients who can walk
Sarepta Therapeutics said on Monday it will resume shipping of its muscular disorder gene therapy to patients who can walk, sending the company's shares 59% higher in extended trading.
MIT Technology Review · 4d
The deadly saga of the controversial gene therapy Elevidys
The drug, which was designed to treat Duchenne muscular dystrophy, has been linked to the deaths of two teenage boys.
13hon MSN
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
By Bhanvi Satija and Siddhi Mahatole (Reuters) -Sarepta Therapeutics shares snapped a three-day losing streak on Tuesday, as ...
1d
Sarepta Therapeutics to Lift Pause on Shipments of Duchenne Treatment Elevidys
Sarepta Therapeutics said the Food and Drug Administration informed the company it can lift a voluntary pause on shipments of Elevidys for ambulatory patients with Duchenne. The company said Monday ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Tsunami watch for CA coast
Senate confirms Emil Bove
EPA moves to repeal finding
Backs Palestinian state
Three men convicted in theft
Announces bid for 4th term
House panel rejects request
Police release picture
Won’t run for governor
DOJ files formal complaint
Ending password autofill
Kicked by horse, breaks rib
To hike US prices
Wins 1,500m freestyle
Fukushima faces new delay
To furlough pilots
Exits NC Senate race
Sued over trans bias cases
Goods trade deficit narrows
FDA official departs agency
UCLA ends antisemitism suit
Merck to cut jobs
Partnership gets DOT nod
Introduces 'study mode'
Angola fuel hike protests
RU strike kills at least 22
To buy Norfolk Southern
US job openings fall in June
On kratom-related products
Consumer confidence rises
AI tool to detect teen users

Related topics

Sarepta Therapeutics
Food and Drug Administration
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy